IP Library Granted Patent US 7,224,521
Granted Patent B2
US 7,224,521 · App. 10/940,063 · Granted May 29, 2007

Parcentric objective

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,224,521
App. No.
10/940,063
Granted
May 29, 2007
Kind
B2
Abstract

A parcentric objective is described, including an objective lens configured to receive an incident ray from a field of view and to translate the incident ray into a translated incident ray, the objective lens substantially aligned across an optical axis, and a wedge prism configured to receive and deflect the translated incident ray into an exiting ray, the wedge prism rotated about the optical axis. A specimen review system is also described, including a specimen stage configured to receive specimens for viewing, a source of illumination providing illumination to the specimen stage, a review scope configured to review specimens positioned on the specimen stage, the review scope comprising a parcentric objective configured to resolve a field of view of the specimen stage.

Claims (27)

1. A biological specimen review device, comprising:

an illumination source configured to illuminate the biological specimen;

a translatable objective lens configured to receive an incident ray from a field of view of the biological specimen and to translate the incident ray into a translated incident ray, the objective lens substantially aligned across an optical axis and being translatable in a direction substantially perpendicular to the optical axis; and

a wedge prism configured to receive and deflect the translated incident ray into an exiting ray directed against an aperture, the wedge prism being rotatable about the optical axis, and wherein the objective lens is translatable relative to the wedge prism such that the exiting ray has a range of deflection without an area of exclusion.

2. The biological specimen review device of claim 1 , wherein a characteristic of the exiting ray is controlled by the wedge prism.

3. The biological specimen review device of claim 2 , wherein the characteristic is a direction.

4. The biological specimen review device of claim 2 , wherein the characteristic is an angle of deflection.

5. The biological specimen review device of claim 2 , wherein the characteristic is a range of deflection.

6. The biological specimen review device of claim 2 , wherein the characteristic is a degree of freedom.

7. The biological specimen review device of claim 2 , wherein the characteristic is a chromatic aberration.

8. The biological specimen review device of claim 1 , wherein a characteristic of the exiting ray is controlled by the objective lens.

9. The biological specimen review device of claim 8 , wherein the characteristic is a direction.

10. The biological specimen review device of claim 8 , wherein the characteristic is an angle of deflection.

11. The biological specimen review device of claim 8 , wherein the characteristic is a range of deflection.

12. The biological specimen review device of claim 8 , wherein the characteristic is a degree of freedom.

13. The biological specimen review device of claim 1 , wherein a characteristic of the exiting ray is controlled by rotation of the wedge prism relative to the optical axis.

14. The biological specimen review device of claim 1 , wherein a material of the wedge prism determines a dependency of deflection upon a wavelength of the exiting ray.

15. The biological specimen review device of claim 1 , wherein the exiting ray is deflected in a continuous region having a first degree of freedom associated with translation of the objective lens across the optical axis.

16. The biological specimen review device of claim 1 , wherein the exiting ray is deflected in a continuous region having a first degree of freedom associated with translation of the objective lens across the optical axis and a second degree of freedom associated with rotation of the wedge prism about the optical axis.

17. The biological specimen review device of claim 1 , wherein the exiting ray is substantially parallel to the incident ray.

18. The biological specimen review device of claim 1 , wherein the exiting ray is deflected in a range of deflection relative to the optical axis, the range of deflection comprising a convolution of a circle generated by rotation of the wedge prism about the optical axis and a curvilinear path generated by translation of the objective lens across the optical axis.

19. A method for viewing a biological specimen, comprising:

receiving an incident ray from a field of view of the biological specimen;

translating the incident ray into a translated incident ray using a translatable objective lens that is translatable in a direction substantially perpendicular to the optical axis;

deflecting the translated incident ray with a rotatable wedge prism into an exiting ray directed against an aperture such that the exiting ray has a range of deflection without an area of exclusion.

20. The method of claim 19 , further comprising

controlling a range of deflection of the exiting ray using the wedge prism.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →